Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

L. Khoja; E. G. Atenafu; S. Suciu; S. Leyvraz; T. Sato; E. Marshall; U. Keilholz; L. Zimmer; S. P. Patel; S. Piperno-Neumann; J. Piulats; T. T. Kivela; C. Pfoehler; S. Bhatia; P. Huppert; L. B. J. Van Iersel; I. J. M. De Vries; N. Penel; T. Vogl; T. Cheng; G. Fiorentini; F. Mouriaux; A. Tarhini; P. M. Patel; R. Carvajal; A. M. Joshua

doi:10.1093/annonc/mdz176

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

L. Khoja, E. G. Atenafu, S. Suciu, S. Leyvraz, T. Sato, E. Marshall, U. Keilholz, L. Zimmer, S. P. Patel, S. Piperno-Neumann, J. Piulats, T. T. Kivela, C. Pfoehler, S. Bhatia, P. Huppert, L. B. J. Van Iersel, I. J. M. De Vries, N. Penel, T. Vogl, T. ChengG. Fiorentini, F. Mouriaux, A. Tarhini, P. M. Patel, R. Carvajal, A. M. Joshua^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1370-1380
Number of pages	11
Journal	Annals of Oncology
Volume	30
Issue number	8
DOIs	https://doi.org/10.1093/annonc/mdz176
Publication status	Published - Aug 2019

Keywords

meta-analysis
uveal melanoma
trial design
survival benchmarks
STAGE-IV MELANOMA
PHASE-II TRIAL
GEMCITABINE PLUS TREOSULFAN
LIVER METASTASES
CHEMOEMBOLIZATION TACE
CHOROIDAL MELANOMA
1ST-LINE TREATMENT
INTRAARTERIAL
TEMOZOLOMIDE
COMBINATION

Access to Document

10.1093/annonc/mdz176

Cite this

Khoja, L., Atenafu, E. G., Suciu, S., Leyvraz, S., Sato, T., Marshall, E., Keilholz, U., Zimmer, L., Patel, S. P., Piperno-Neumann, S., Piulats, J., Kivela, T. T., Pfoehler, C., Bhatia, S., Huppert, P., Van Iersel, L. B. J., De Vries, I. J. M., Penel, N., Vogl, T., ... Joshua, A. M. (2019). Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. Annals of Oncology, 30(8), 1370-1380. https://doi.org/10.1093/annonc/mdz176

Khoja, L. ; Atenafu, E. G. ; Suciu, S. ; Leyvraz, S. ; Sato, T. ; Marshall, E. ; Keilholz, U. ; Zimmer, L. ; Patel, S. P. ; Piperno-Neumann, S. ; Piulats, J. ; Kivela, T. T. ; Pfoehler, C. ; Bhatia, S. ; Huppert, P. ; Van Iersel, L. B. J. ; De Vries, I. J. M. ; Penel, N. ; Vogl, T. ; Cheng, T. ; Fiorentini, G. ; Mouriaux, F. ; Tarhini, A. ; Patel, P. M. ; Carvajal, R. ; Joshua, A. M. / Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks : an international rare cancers initiative (IRCI) ocular melanoma study. In: Annals of Oncology. 2019 ; Vol. 30, No. 8. pp. 1370-1380.

@article{97b3c7beb89f4729b8f8390c8aeaf58f,

title = "Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study",

keywords = "meta-analysis, uveal melanoma, trial design, survival benchmarks, STAGE-IV MELANOMA, PHASE-II TRIAL, GEMCITABINE PLUS TREOSULFAN, LIVER METASTASES, CHEMOEMBOLIZATION TACE, CHOROIDAL MELANOMA, 1ST-LINE TREATMENT, INTRAARTERIAL, TEMOZOLOMIDE, COMBINATION",

author = "L. Khoja and Atenafu, {E. G.} and S. Suciu and S. Leyvraz and T. Sato and E. Marshall and U. Keilholz and L. Zimmer and Patel, {S. P.} and S. Piperno-Neumann and J. Piulats and Kivela, {T. T.} and C. Pfoehler and S. Bhatia and P. Huppert and {Van Iersel}, {L. B. J.} and {De Vries}, {I. J. M.} and N. Penel and T. Vogl and T. Cheng and G. Fiorentini and F. Mouriaux and A. Tarhini and Patel, {P. M.} and R. Carvajal and Joshua, {A. M.}",

year = "2019",

month = aug,

doi = "10.1093/annonc/mdz176",

language = "English",

volume = "30",

pages = "1370--1380",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "8",

}

Khoja, L, Atenafu, EG, Suciu, S, Leyvraz, S, Sato, T, Marshall, E, Keilholz, U, Zimmer, L, Patel, SP, Piperno-Neumann, S, Piulats, J, Kivela, TT, Pfoehler, C, Bhatia, S, Huppert, P, Van Iersel, LBJ, De Vries, IJM, Penel, N, Vogl, T, Cheng, T, Fiorentini, G, Mouriaux, F, Tarhini, A, Patel, PM, Carvajal, R & Joshua, AM 2019, 'Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study', Annals of Oncology, vol. 30, no. 8, pp. 1370-1380. https://doi.org/10.1093/annonc/mdz176

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks : an international rare cancers initiative (IRCI) ocular melanoma study. / Khoja, L.; Atenafu, E. G.; Suciu, S.; Leyvraz, S.; Sato, T.; Marshall, E.; Keilholz, U.; Zimmer, L.; Patel, S. P.; Piperno-Neumann, S.; Piulats, J.; Kivela, T. T.; Pfoehler, C.; Bhatia, S.; Huppert, P.; Van Iersel, L. B. J.; De Vries, I. J. M.; Penel, N.; Vogl, T.; Cheng, T.; Fiorentini, G.; Mouriaux, F.; Tarhini, A.; Patel, P. M.; Carvajal, R.; Joshua, A. M.

In: Annals of Oncology, Vol. 30, No. 8, 08.2019, p. 1370-1380.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks

T2 - an international rare cancers initiative (IRCI) ocular melanoma study

AU - Khoja, L.

AU - Atenafu, E. G.

AU - Suciu, S.

AU - Leyvraz, S.

AU - Sato, T.

AU - Marshall, E.

AU - Keilholz, U.

AU - Zimmer, L.

AU - Patel, S. P.

AU - Piperno-Neumann, S.

AU - Piulats, J.

AU - Kivela, T. T.

AU - Pfoehler, C.

AU - Bhatia, S.

AU - Huppert, P.

AU - Van Iersel, L. B. J.

AU - De Vries, I. J. M.

AU - Penel, N.

AU - Vogl, T.

AU - Cheng, T.

AU - Fiorentini, G.

AU - Mouriaux, F.

AU - Tarhini, A.

AU - Patel, P. M.

AU - Carvajal, R.

AU - Joshua, A. M.

PY - 2019/8

Y1 - 2019/8

KW - meta-analysis

KW - uveal melanoma

KW - trial design

KW - survival benchmarks

KW - STAGE-IV MELANOMA

KW - PHASE-II TRIAL

KW - GEMCITABINE PLUS TREOSULFAN

KW - LIVER METASTASES

KW - CHEMOEMBOLIZATION TACE

KW - CHOROIDAL MELANOMA

KW - 1ST-LINE TREATMENT

KW - INTRAARTERIAL

KW - TEMOZOLOMIDE

KW - COMBINATION

U2 - 10.1093/annonc/mdz176

DO - 10.1093/annonc/mdz176

M3 - Article

VL - 30

SP - 1370

EP - 1380

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 8

ER -